𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reintroduction of etanercept during treatment of cutaneousMycobacterium marinuminfection in a patient with ankylosing spondylitis

✍ Scribed by Dare, Jason A. ;Jahan, Shormi ;Hiatt, Kim ;Torralba, Karina D.

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
118 KB
Volume
61
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Six-month results of a double-blind, pla
Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis
✍ J. Brandt; A. Khariouzov; J. Listing; H. Haibel; H. SΓΆrensen; L. Grassnickel; M. πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 118 KB πŸ‘ 2 views

## Abstract ## Objective There is increasing evidence that tumor necrosis factor Ξ± (TNFΞ±) is centrally involved in the pathogenesis of ankylosing spondylitis (AS) and other spondylarthritides. This study was designed to investigate the efficacy of anti‐TNFΞ± therapy with etanercept, a 75‐kd recepto